[1]Aroda,V.R.,et al.,PIONEER 1:Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes.Diabetes Care,2019.42(9):p.1724-1732. [2...
[6].Rosenstock J, Allison D, Birkenfeld AL, et al. Effect of additional oral semaglutide vs sitagliptin on glycated hemoglobin in adults with type 2 diabetes uncontrolled with metformin alone or with sulfonylurea: the PIONEER 3...
[6]. Rosenstock J, Allison D, Birkenfeld AL, et al. Effect of additional oral semaglutide vs sitagliptin on glycated hemoglobin in adults with type 2 diabetes uncontrolled with metformin alone or with sulfonylurea: the PIONEER 3 randomized clinical trial[J]. JAMA, 2019,321(15):1466-1480. doi...
[6]. Rosenstock J, Allison D, Birkenfeld AL, et al. Effect of additional oral semaglutide vs sitagliptin on glycated hemoglobin in adults with type 2 diabetes uncontrolled with metformin alone or with sulfonylurea: the PIONEER ...
3. Rosenstock, J., et al., Effect of Additional Oral Semaglutide vs Sitagliptin on Glycated Hemoglobin in Adults With Type 2 Diabetes Uncontrolled With Metformin Alone or With Sulfonylurea: The PIONEER 3 Randomized Clinical ...
[1] Lansky AJ, Kereiakes DJ, Baumbach A, et al. Novel SupremeTMDES with Early Synchronized Antiproliferative Drug Delivery to Inhibit Smooth Muscle Cell Proliferation after DES implantation in Coronary Artery Disease: Results of the PIONEER III Randomized Clinical Trial. Circulation. 2021, Apr 6....
China's deep-sea heavy-duty mining vehicle has completed a sea trial at a depth exceeding 4,000 meters, marking a significant breakthrough in the country's deep-sea mineral resource development technology. The trial was conducted by "Pioneer II", an engineering prototype developed independently ...
Kate Foster
Will Stronge said,“This study shows that the world's largest trial of a shorter working week in the public sector was very 23..It shows that the public sector is a 24.of shorter working weeks-and lessons can be learned for other governments. "Spain is trying it because of the 25.of...
(PIONEER-HF trial) 研究背景 目前,美国约有570万人和中国约有420万人因心力衰竭而诊断出心衰。由于人口老龄化,心力衰竭的病人也在上升。在美国,每年有超过100万人由于急性失代偿性心力衰竭 (ADHF)需要住院治疗,这也给医疗费用带来了沉重的经济负担。 根据目前的指南建议, ...